Back to search

Article

When AI Meets the FDA: An Evaluation of Large Language Models Performance in Regulatory and Clinical Trial Data Extraction, Synthesis, and Analysis

2025-12-27

Abstract excerpt

<h4>Introduction:</h4> Clinical and population decision-making relies on the systematic evaluation of extensive regulatory evidence. The FDA drug reviews provide detailed information on clinical trial design, enrollment criteria, sample size, randomization, comparators, endpoints, and indications. However, extracting these data is resource-intensive and time-consuming. Generative Artificial Intelligence large lan...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
46362abd-506b-5a1b-b6c7-276bcfb6aab0
DOI
10.64898/2025.12.22.25342875
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
When AI Meets the FDA: An Evaluation of Large Language Models Performance in Regulatory and Clinical Trial Data Extraction, Synthesis, and AnalysisDOI 10.64898/2025.12.22.25342875
Select a neighboring publication to make it the new centre.